185 related articles for article (PubMed ID: 22263918)
1. Evaluation of the pharmacokinetics of linezolid in an obese Japanese patient.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Sakamoto S; Morita K; Yukawa E; Kamimura H; Karube Y
Scand J Infect Dis; 2012 Aug; 44(8):626-9. PubMed ID: 22263918
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum linezolid concentrations in two patients receiving linezolid and rifampicin due to bone infections.
Hoyo I; Martínez-Pastor J; Garcia-Ramiro S; Climent C; Brunet M; Cuesta M; Mensa J; Soriano A
Scand J Infect Dis; 2012 Jul; 44(7):548-50. PubMed ID: 22385321
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerance of linezolid for meticillin-resistant Staphylococcus aureus mediastinitis in paediatric patients.
Kosaka T; Kokufu T; Shime N; Sugioka N; Kato R; Hamaoka K; Fujita N
Int J Antimicrob Agents; 2009 Apr; 33(4):368-70. PubMed ID: 19097868
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetic analysis of linezolid in low body weight patients with renal dysfunction.
Tsuji Y; Yukawa E; Hiraki Y; Matsumoto K; Mizoguchi A; Morita K; Kamimura H; Karube Y; To H
J Clin Pharmacol; 2013 Sep; 53(9):967-73. PubMed ID: 23918457
[TBL] [Abstract][Full Text] [Related]
5. Linezolid in the central nervous system: comparison between cerebrospinal fluid and plasma pharmacokinetics.
Viaggi B; Paolo AD; Danesi R; Polillo M; Ciofi L; Del Tacca M; Malacarne P
Scand J Infect Dis; 2011 Sep; 43(9):721-7. PubMed ID: 21585240
[TBL] [Abstract][Full Text] [Related]
6. Oral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?
Hamilton R; Thai XC; Ameri D; Pai MP
J Antimicrob Chemother; 2013 Mar; 68(3):666-73. PubMed ID: 23160755
[TBL] [Abstract][Full Text] [Related]
7. Plasma exposure of free linezolid and its ratio to minimum inhibitory concentration varies in critically ill patients.
Yagi T; Naito T; Doi M; Nagura O; Yamada T; Maekawa M; Sato S; Kawakami J
Int J Antimicrob Agents; 2013 Oct; 42(4):329-34. PubMed ID: 23988716
[TBL] [Abstract][Full Text] [Related]
8. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections.
Stein GE; Schooley S; Peloquin CA; Missavage A; Havlichek DH
J Antimicrob Chemother; 2007 Oct; 60(4):819-23. PubMed ID: 17673476
[TBL] [Abstract][Full Text] [Related]
9. Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion.
Adembri C; Fallani S; Cassetta MI; Arrigucci S; Ottaviano A; Pecile P; Mazzei T; De Gaudio R; Novelli A
Int J Antimicrob Agents; 2008 Feb; 31(2):122-9. PubMed ID: 18055183
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of oral linezolid compared with intravenous vancomycin for the treatment of methicillin-resistant Staphylococcus aureus-complicated skin and soft tissue infections: a retrospective, propensity score-matched, case-control analysis.
Itani KM; Biswas P; Reisman A; Bhattacharyya H; Baruch AM
Clin Ther; 2012 Aug; 34(8):1667-73.e1. PubMed ID: 22770644
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.
Buerger C; Plock N; Dehghanyar P; Joukhadar C; Kloft C
Antimicrob Agents Chemother; 2006 Jul; 50(7):2455-63. PubMed ID: 16801426
[TBL] [Abstract][Full Text] [Related]
13. The effect of food on plasma and tissue concentrations of linezolid after multiple doses.
Islinger F; Dehghanyar P; Sauermann R; Bürger C; Kloft C; Müller M; Joukhadar C
Int J Antimicrob Agents; 2006 Feb; 27(2):108-12. PubMed ID: 16388930
[TBL] [Abstract][Full Text] [Related]
14. Alveolar diffusion and pharmacokinetics of linezolid administered in continuous infusion to critically ill patients with ventilator-associated pneumonia.
Boselli E; Breilh D; Caillault-Sergent A; Djabarouti S; Guillaume C; Xuereb F; Bouvet L; Rimmelé T; Saux MC; Allaouchiche B
J Antimicrob Chemother; 2012 May; 67(5):1207-10. PubMed ID: 22351682
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.
Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; Pichardo C; Ibáñez-Martínez J; Pachón J
J Antimicrob Chemother; 2012 Aug; 67(8):1961-7. PubMed ID: 22532466
[TBL] [Abstract][Full Text] [Related]
17. Plasma and cerebrospinal fluid concentrations of linezolid in neurosurgical critically ill patients with proven or suspected central nervous system infections.
Luque S; Grau S; Alvarez-Lerma F; Ferrández O; Campillo N; Horcajada JP; Basas M; Lipman J; Roberts JA
Int J Antimicrob Agents; 2014 Nov; 44(5):409-15. PubMed ID: 25216547
[TBL] [Abstract][Full Text] [Related]
18. Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.
Matsumoto K; Shigemi A; Takeshita A; Watanabe E; Yokoyama Y; Ikawa K; Morikawa N; Takeda Y
J Infect Chemother; 2015 Jan; 21(1):70-3. PubMed ID: 25305808
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of linezolid in human non-inflamed vitreous after systemic administration.
Horcajada JP; Atienza R; Sarasa M; Soy D; Adán A; Mensa J
J Antimicrob Chemother; 2009 Mar; 63(3):550-2. PubMed ID: 19109336
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and protein binding of linezolid in cerebrospinal fluid and serum in a case of post-neurosurgical bacterial meningitis.
Tsuji Y; Hiraki Y; Matsumoto K; Mizoguchi A; Sadoh S; Kobayashi T; Takemura Y; Sakamoto S; Morita K; Kamimura H; Karube Y
Scand J Infect Dis; 2011 Dec; 43(11-12):982-5. PubMed ID: 21851332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
